Cargando…
Interleukin 32 as a Potential Marker for Diagnosis of Tuberculous Pleural Effusion
Accurate differential diagnosis is the key to choosing the correct treatment for pleural effusion. The present study aimed to assess whether interleukin 32 (IL-32) could be a new biomarker of tuberculous pleural effusion (TPE) and to explore the biological role of IL-32 in TPE. IL-32 levels were eva...
Autores principales: | Du, Juan, Shao, Ming-Ming, Yi, Feng-Shuang, Huang, Zhong-Yin, Qiao, Xin, Chen, Qing-Yu, Shi, Huan-Zhong, Zhai, Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430160/ https://www.ncbi.nlm.nih.gov/pubmed/35880892 http://dx.doi.org/10.1128/spectrum.02553-21 |
Ejemplares similares
-
Hepatocyte growth factor combined with adenosine deaminase as biomarker for diagnosis of tuberculous pleural effusion
por: Zheng, Sheng-Cai, et al.
Publicado: (2023) -
Complement Component C1q as an Emerging Biomarker for the Diagnosis of Tuberculous Pleural Effusion
por: Qiao, Xin, et al.
Publicado: (2021) -
Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions
por: Liu, Ya-Lan, et al.
Publicado: (2016) -
Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion
por: Gu, Yan, et al.
Publicado: (2016) -
Tuberculous Pleural Effusion
por: Schlesinger, Shira A., et al.
Publicado: (2012)